Literature DB >> 31582169

Fcγ receptors and toll-like receptor 9 synergize to drive immune complex-induced dendritic cell maturation.

Nicole L J Nelson1, Cheryl M Zajd2, Michelle R Lennartz2, Edmund J Gosselin3.   

Abstract

Previous in vivo studies established that inactivated Francisella tularensis immune complexes (mAb-iFt) are a more protective vaccine against lethal tularemia than iFt alone. Subsequent in vitro studies revealed enhanced DC maturation marker expression with mAb-iFt stimulation. The goal of this study was to determine the mechanism of enhanced DC maturation. Multiparameter analysis of surface marker expression and cytokine secretion demonstrates a requirement for FcγR signaling in enhanced DC maturation. MyD88 was also found to be essential for heightened DC maturation, implicating MyD88-dependent TLRs in DC maturation. Upon further study, we discovered that TLRs 2 & 4 drive cytokine secretion, but surprisingly TLR9 is required for DC maturation marker upregulation. These studies reveal a separation of DC cytokine and maturation marker induction pathways and demonstrate that FcγR-TLR/MyD88 synergy underlies the enhanced dendritic cell maturation in response to the mAb-iFt vaccine.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dendritic cell maturation; Fcγ receptors; Flow cytometry; Francisella tularensis; Immune complex; MyD88; TLR2; TLR9

Mesh:

Substances:

Year:  2019        PMID: 31582169      PMCID: PMC6892604          DOI: 10.1016/j.cellimm.2019.103962

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  42 in total

Review 1.  Fc-receptors as regulators of immunity.

Authors:  Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Adv Immunol       Date:  2007       Impact factor: 3.543

Review 2.  Fcgamma receptors as regulators of immune responses.

Authors:  Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Nat Rev Immunol       Date:  2008-01       Impact factor: 53.106

3.  Role of CD80 (B7.1) and CD86 (B7.2) in the immune response to an intracellular pathogen.

Authors:  C S Subauste; R de Waal Malefyt; F Fuh
Journal:  J Immunol       Date:  1998-02-15       Impact factor: 5.422

4.  FcRγ deficiency improves survival in experimental sepsis by down-regulating TLR4 signaling pathway.

Authors:  Zhi-Min Wei; Zhuo Wang; Xiao-Jian Wan; Xian-Jing Li; Yi-Xing Li; Yang Bai; Xue Yang; Yong Yang; Shun-Chang Jiao; Zhe-Feng Liu
Journal:  Immunol Res       Date:  2019-02       Impact factor: 2.829

5.  Oxidized Low-Density Lipoprotein Immune Complex Priming of the Nlrp3 Inflammasome Involves TLR and FcγR Cooperation and Is Dependent on CARD9.

Authors:  Jillian P Rhoads; John R Lukens; Ashley J Wilhelm; Jared L Moore; Yanice Mendez-Fernandez; Thirumala-Devi Kanneganti; Amy S Major
Journal:  J Immunol       Date:  2017-01-27       Impact factor: 5.422

6.  Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9.

Authors:  Terry K Means; Eicke Latz; Fumitaka Hayashi; Mandakolathur R Murali; Douglas T Golenbock; Andrew D Luster
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

7.  Modeling immune complex-mediated autoimmune inflammation.

Authors:  A Arazi; A U Neumann
Journal:  J Theor Biol       Date:  2010-09-09       Impact factor: 2.691

Review 8.  Immunomodulatory Bonds of the Partnership between Dendritic Cells and T Cells.

Authors:  Jessica Bourque; Daniel Hawiger
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

9.  Utilization of Fc receptors as a mucosal vaccine strategy against an intracellular bacterium, Francisella tularensis.

Authors:  Deepak B Rawool; Constantine Bitsaktsis; Ying Li; Diane R Gosselin; Yili Lin; Nitin V Kurkure; Dennis W Metzger; Edmund J Gosselin
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

10.  Immune complexes stimulate CCR7-dependent dendritic cell migration to lymph nodes.

Authors:  Menna R Clatworthy; Caren E Petrie Aronin; Rebeccah J Mathews; Nicole Y Morgan; Kenneth G C Smith; Ronald N Germain
Journal:  Nat Med       Date:  2014-11-10       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.